Author:
Tao Kaiming,Zhou Jinru,Nagarajan Pavithra,Tzou Philip,Shafer Robert W.
Reference70 articles.
1. HIV-1 Protease, Reverse Transcriptase, and Integrase Variation;S-Y Rhee;J Virol,2016
2. High-level resistance to (-) enantiomeric 2'deoxy-3'-thiacytidine in vitro is due to one amino acid substitution in the catalytic site of human immunodeficiency virus type 1 reverse transcriptase;C A Boucher;Antimicrobial Agents and Chemotherapy,1993
3. HIV-1 strains belonging to large phylogenetic clusters show accelerated escape from integrase inhibitors in cell culture compared with viral isolates from singleton/small clusters;B G Brenner;Journal of Antimicrobial Chemotherapy,2017
4. Differential In Vitro Kinetics of Drug Resistance Mutation Acquisition in HIV-1 RT of Subtypes B and C;R D Cunha;PLOS ONE,2012
5. The same mutation that encodes low-level human immunodeficiency virus type 1 resistance to 2',3'-dideoxyinosine and 2',3'-dideoxycytidine confers high-level resistance to the (-) enantiomer of 2',3'-dideoxy-3'-thiacytidine;Q Gao;Antimicrobial Agents and Chemotherapy,1993